Quimatryx Is A Private Biotech Company Based In Donostiaspainfounded In 2015The Company Focuses On Developing Innovative Drugs That Target Epigenetic Mechanismsparticularly In Cancer Treatmenttheir Lead Compoundqtx125Is A Selective Hdac6 Inhibitor That Has Demonstrated Strong Pre Clinical Evidence Of Safety And Efficacy Against Non Hodgkin Lymphoma Quimatryx Is Currently In The Pre Clinical Phase For Qtx125 And Is Seeking Funding To Advance The Compound Into Clinical Trialsthe Company Has Established Strategies For Good Manufacturing Practicegmpcompliant Production To Support Future Studiesquimatryx Also Holds A Robust Intellectual Property Position That Protects Its Innovations Until 2042
No conferences found for this company.
| Company Name | Quimatryx Sl |
| Country |
Spain
|
| Address | N/A |
| Telephone | N/A |
| N/A |
